Diagnostic value of cardiac magnetic resonance and fluorodeoxyglucose-positron emission tomography for cardiac sarcoidosis with previous myocardial infarction A case report

被引:0
|
作者
Yasuda, Masakazu [1 ,2 ]
Iwanaga, Yoshitaka [1 ]
Kawamura, Takayuki [1 ]
Nakamura, Takashi [1 ]
De Rosa, Salvatore [2 ]
Indolfi, Ciro [2 ,3 ]
Miyazaki, Shunichi [1 ]
机构
[1] Kindai Univ, Dept Internal Med, Div Cardiol, Fac Med, 377-2 Ohno Higashi, Osakasayama, Osaka, Japan
[2] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Div Carriol, Catanzaro, Italy
[3] Magna Graecia Univ Catanzaro, URT CNR IFC, Viale Europa Localita, Catanzaro, Italy
关键词
cardiac magnetic resonance; fluorodeoxyglucose-positron emission tomography; myocardial infarction; sarcoidosis; DELAYED ENHANCEMENT;
D O I
10.1097/MD.0000000000011938
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rationale: Diagnostic difficulty due to overlapped clinical findings exists in cardiac sarcoidosis (CS) patients who also have coronary artery disease. Since cardiac magnetic resonance (CMR) and fluorodeoxyglucose-positron emission tomography (FDG-PET) evaluate different pathological processes, that is, fibrosis and inflammation respectively, the combination may be useful in such a case. Patient concerns: A 77-year-old man was admitted due to heart failure and advanced atrioventricular block who was previously diagnosed with cutaneous sarcoidosis and old myocardial infarction (MI) with angiographical evidence. Diagnosis: He was finally diagnosed with CS using CMR and FDG-PET by specifying the myocardial lesion of sarcoidosis. Interventions: He was treated with corticosteroids based on the diagnosis. Outcomes: The focal high uptake on FDG-PET was improved and he had a better clinical course without further cardiac events. Lessons: Our case suggests that CMR and FDG-PET are complimentary, and the combination is useful for diagnosis of CS, particularly in cases that have previous MI.
引用
收藏
页数:4
相关论文
共 50 条
  • [41] A new era of imaging for diagnosis and management of cardiac sarcoidosis: Hybrid cardiac magnetic resonance imaging and positron emission tomography
    Monica Ahluwalia
    Stephen Pan
    Munir Ghesani
    Lawrence M. Phillips
    Journal of Nuclear Cardiology, 2019, 26 : 1996 - 2004
  • [42] Fluorodeoxyglucose-positron emission tomography/computed tomography imaging features of colloid adenocarcinoma of the lung: A case report
    Wang Z.
    Yu M.
    Chen Y.
    Kong Y.
    Journal of Medical Case Reports, 11 (1)
  • [43] Utility of Cardiac Magnetic Resonance Imaging Versus Cardiac Positron Emission Tomography for Risk Stratification for Ventricular Arrhythmias in Patients With Cardiac Sarcoidosis
    Gowani, Zain
    Habibi, Mohammadali
    Okada, David R.
    Smith, John
    Derakhshan, Arsalan
    Zimmerman, Stefan L.
    Misra, Satish
    Gilotra, Nisha A.
    Berger, Ronald D.
    Calkins, Hugh
    Tandri, Harikrishna
    Chrispin, Jonathan
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 134 : 123 - 129
  • [44] Fluorodeoxyglucose positron emission tomography in the presence of cardiac metastases
    Nguyen, JD
    Carrasquillo, JA
    Little, RF
    Ryan, QC
    Wilson, W
    Chen, CC
    CLINICAL NUCLEAR MEDICINE, 2003, 28 (12) : 979 - 980
  • [45] Castleman's Disease Presenting as Fever of Unknown Origin: Diagnostic Value of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography
    Roca, Bernardino
    Torres, Vilma
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2009, 337 (04): : 295 - 296
  • [46] Diagnostic accuracy of cardiac computed tomography and 18F-fluorodeoxyglucose with positron emission tomography/computed tomography in cardiac masses
    D'Angelo, E. C.
    Paolisso, P.
    Foa, A.
    Bergamaschi, L.
    Magnani, I
    Toniolo, S.
    Donati, F.
    Rinaldi, A.
    Lovato, L.
    Fanti, S.
    Leone, O.
    Rucci, P.
    Pacini, D.
    Galie, N.
    Pizzi, C.
    EUROPEAN HEART JOURNAL, 2020, 41 : 294 - 294
  • [47] Diagnostic accuracy of cardiac computed tomography and F-fluorodeoxyglucose positron emission tomography/computed tomography in the identification of cardiac masses
    ConcettaD'Angelo, Emanuela
    Paolisso, Pasquale
    Vitale, Giovanni
    Foa, Alberto
    Bergamaschi, Luca
    Magnani, Ilenia
    Toniolo, Sebastiano
    Saturi, Giulia
    Rinaldi, Andrea
    Leone, Ornella
    Pantaleo, Maria Abbondanza
    Pacini, Davide
    Pizzi, Carmine
    Galie, Nazzareno
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0J) : J70 - J71
  • [48] Cardiac cavernous hemangioma with high fluorodeoxyglucose uptake on preoperative positron emission tomography/computed tomography: a case report
    Kobayashi, Takuma
    Numata, Satoshi
    Hohri, Yu
    Kawajiri, Hidetake
    Yaku, Hitoshi
    GENERAL THORACIC AND CARDIOVASCULAR SURGERY CASES, 2023, 2 (01):
  • [49] Effect of Corticosteroid Dose and Duration on 18-Fluorodeoxyglucose Positron Emission Tomography in Cardiac Sarcoidosis
    Okada, David R.
    Saad, Elie
    Wand, Alison L.
    Griffin, Jan M.
    Kasper, Edward K.
    Chen, Edward H.
    Chrispin, Jonathan
    Tandri, Harikrishna
    Solnes, Lilja B.
    Gilotra, Nisha A.
    JACC-CARDIOVASCULAR IMAGING, 2020, 13 (05) : 1280 - 1282
  • [50] Comparison of cardiac magnetic resonance imaging and fluorodeoxyglucose positron emission tomography in the assessment of myocardial viability: meta-analysis and systematic review
    Mehul Adhaduk
    Bishow Paudel
    Kan Liu
    Mahi Ashwath
    Milena A. Gebska
    Kimberly Delcour
    Riley J. Samuelson
    Michael Giudici
    Journal of Nuclear Cardiology, 2023, 30 : 2514 - 2524